Lipiodol Localization for Ground-glass-opacity Minimal Surgery

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Severance Hospital
• Collaborators: Asan Medical Center; Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Dankook University; Gangnam Severance Hospital; Korea University Anam Hospital; Pusan National University Hospital; Wonju Severance Christian Hospital
• Treatments: Ethiodized Oil

Criteria

Inclusion Criteria:

• Consenting adult patients ≥ 20 years of age

• Pulmonary lesion with a ground glass opacity(GGO)component of more than 50%

• Patient with lesion size less than 3cm

• Persistence or growth of the established lesion within a three month period

• Patient who are not contraindicated to surgery

• Patients who are willing to sign the informed consent form

Exclusion Criteria:

• Patients with solid pulmonary lesion

• Patients with multiple GGOs need multiple localization

• Patients who are contraindicated to surgery

• Patients who behave in an uncooperative manner

• Unwilling or unable to give informed consent

• Pregnant women